2015). Recently, Reho et al. identified 14 miRNAs associated with AD risk in a multiethnic cohort, with many of them targeting the microtubule‐associated protein tau (MAPT) gene (Reho et al. 2025). This evidence concerns the gene MAPT and Alzheimer disease.